Abstract 6604: Drug responsive domain regulation of IL15-engineered T cells provides pharmacological control over antigen-independent cell expansion

MLA

Grace Y. Olinger, et al. “Abstract 6604: Drug Responsive Domain Regulation of IL15-Engineered T Cells Provides Pharmacological Control over Antigen-Independent Cell Expansion.” Cancer Research, vol. 80, Aug. 2020, p. 6604. EBSCOhost, https://doi.org/10.1158/1538-7445.am2020-6604.

APA

Grace Y. Olinger, Celeste Richardson, Michael Gallo, Tucker Ezell, Sethi Dhruv Kam, Dexue Sun, Mara Christine Inniss, Jennifer L. Gori, Vipin Suri, Michelle Fleury, Steven M. Shamah, Karen Tran, Heller Scott Francis, Kutlu G. Elpek, & Meghan Langley. (2020). Abstract 6604: Drug responsive domain regulation of IL15-engineered T cells provides pharmacological control over antigen-independent cell expansion. Cancer Research, 80, 6604. https://doi.org/10.1158/1538-7445.am2020-6604

Chicago

Grace Y. Olinger, Celeste Richardson, Michael Gallo, Tucker Ezell, Sethi Dhruv Kam, Dexue Sun, Mara Christine Inniss, et al. 2020. “Abstract 6604: Drug Responsive Domain Regulation of IL15-Engineered T Cells Provides Pharmacological Control over Antigen-Independent Cell Expansion.” Cancer Research 80 (August): 6604. doi:10.1158/1538-7445.am2020-6604.